Cargando…
Promoterless gene targeting without nucleases ameliorates haemophilia B in mice
Site-specific gene addition can allow stable transgene expression for gene therapy. When possible, this is preferred over the use of promiscuously integrating vectors, which are sometimes associated with clonal expansion(1) and oncogenesis(2). Site-specific endonucleases that can induce high rates o...
Autores principales: | Barzel, A., Paulk, N.K., Shi, Y., Huang, Y., Chu, K., Zhang, F., Valdmanis, P.N., Spector, L.P., Porteus, M.H., Gaensler, K.M., Kay, M.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4297598/ https://www.ncbi.nlm.nih.gov/pubmed/25363772 http://dx.doi.org/10.1038/nature13864 |
Ejemplares similares
-
Promoterless gene targeting without nucleases rescues lethality of a Crigler‐Najjar syndrome mouse model
por: Porro, Fabiola, et al.
Publicado: (2017) -
Promoterless, Nuclease‐Free Genome Editing Confers a Growth Advantage for Corrected Hepatocytes in Mice With Methylmalonic Acidemia
por: Chandler, Randy J., et al.
Publicado: (2021) -
Multiplexed promoterless gene expression with CRISPReader
por: Zhan, Hengji, et al.
Publicado: (2019) -
Promoterless Gene Targeting Approach Combined to CRISPR/Cas9 Efficiently Corrects Hemophilia B Phenotype in Neonatal Mice
por: Lisjak, Michela, et al.
Publicado: (2022) -
Development and characterization of promoterless helper RNAs for the production of alphavirus replicon particle
por: Kamrud, K. I., et al.
Publicado: (2010)